Skip to content

APOTHEEK VALKENBORG

Active Risk: not assessed
Private limited company (pre-2019)founded 200323 yrs activeMeylandtlaan 159, 3550 Heusden-Zolder, BelgiumKBO/BCE: BE 0480.007.666

APOTHEEK VALKENBORG has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €802k and a net result of €-33k. Equity is growing by ~8.4% per year across the filed fiscal years. Its solvency ranks better than 91% of 9195 sector peers (fiscal year 2025). The company has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term

Signals

Three signals. The signal on the left, the evidence on the right.
neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
20 d late
2024
29 d late
2023
24 d late
2022
22 d late
2021
29 d late
2020
30 d late
2019
62 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€802k▼ 4.0%
2024 · €836k
2018: €491k 2019: €574k 2020: €545k 2021: €606k 2022: €688k 2023: €757k 2024: €836k
2018 → 2025
Total assets
€879k▼ 3.8%
2024 · €915k
2018: €792k 2019: €829k 2020: €799k 2021: €820k 2022: €839k 2023: €902k 2024: €915k
2018 → 2025
Net result
€-33k
2024 · €78k
2018: €73k 2019: €84k 2020: €79k 2021: €61k 2022: €82k 2023: €69k 2024: €78k
2018 → 2025
Working capital
€220k▼ 12.8%
2024 · €253k
2018: €-93k 2019: €-9k 2020: €-38k 2021: €17k 2022: €106k 2023: €175k 2024: €253k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€606k-€688k▲ 13.6%€757k▲ 10.0%€836k▲ 10.3%€802k▼ 4.0%
Operating result€77k-€109k▲ 42.6%€99k▼ 9.4%€105k▲ 6.0%€-39k
Net result€61k-€82k▲ 35.3%€69k▼ 16.3%€78k▲ 13.2%€-33k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-50k€0€50k€100kOperating result 2021: €77k€77kNet result 2021: €61k€61kOperating result 2022: €109k€109kNet result 2022: €82k€82kOperating result 2023: €99k€99kNet result 2023: €69k€69kOperating result 2024: €105k€105kNet result 2024: €78k€78kOperating result 2025: €-39k€-39kNet result 2025: €-33k€-33k20212022202320242025
The operating result turns negative in 2025: a loss of €39k after €105k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €879k
Fixed assets €585k▼ 0.1%
Current assets €295k▼ 10.5%
Equity and liabilities €879k
Equity €802k▼ 4.0%
Debt €77k▼ 2.6%
The debt ratio rises from 8.6% to 8.7%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
Solvency
91.3%
2024 · 91.4%
ROE
-4.1%
2024 · 9.4%
ROA
-3.8%
2024 · 8.5%
Debt
€77k
2024 · €79k
Debt ≤ 1 year
€74k
2024 · €77k
Income taxes
€203
2024 · €31k
Staff costs
€117k
2024 · €90k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€915k€879k
Fixed assets21/28€585k€585k
Tangible fixed assets22/27€2k€1k
Furniture and vehicles24€2k€1k
Financial fixed assets28€583k€583k=
Current assets29/58€329k€295k
Amounts receivable after more than one year29€200k€200k=
Other amounts receivable291€200k€200k=
Amounts receivable within one year40/41€120k€87k
Trade receivables40€6€0
Other amounts receivable41€120k€87k
Cash at bank and in hand54/58€91€3
Deferred charges and accrued income490/1€9k€8k
Equity and liabilities
Total equity and liabilities10/49€915k€879k
Equity10/15€836k€802k
Contributions10/11€6k€6k=
Reserves13€829k€829k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€827k€827k=
Profit (loss) carried forward14-€-33k
Amounts payable17/49€79k€77k
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€77k€74k
Current portion of amounts payable after more than one year42€873€13k
Financial debts43€45k€22k
Credit institutions430/8€45k€22k
Trade debts44€8k€12k
Suppliers440/4€8k€12k
Taxes, remuneration and social security45€23k€28k
Taxes450/3€888€3k
Remuneration and social security454/9€22k€25k
Accrued charges and deferred income492/3€2k€2k
Income statement Code20242025
Remuneration, social security and pensions62€90k€117k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€720€720=
Other operating charges640/8€2k€2k
Gross operating margin9900€197k€80k
Operating profit (loss)9901€105k€-39k
Financial income75/76B€9k€10k
Recurring financial income75€9k€10k
Financial charges65/66B€5k€3k
Recurring financial charges65€5k€3k
Profit (loss) for the period before taxes9903€109k€-33k
Income taxes67/77€31k€203
Profit (loss) for the period9904€78k€-33k
Profit (loss) for the period to be appropriated9905€78k€-33k
Appropriation of the result
Profit (loss) to be appropriated9906€78k€-33k
Transfer to equity691/2€78k€0
To other reserves6921€78k€0
Social balance
Average headcount (FTE)90871.92.2

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 20 days late
2025
31-12
Financial Weakest financial yearnet €-33k ▼142%
Net result drops to €-33k, the lowest in the series.
29-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
24-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 24 days late
2023
22-08
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 22 days late
2022
29-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
01-10
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 62 days late
2019
31-12
Financial Highest result since 2018net €84k ▲14.4%
Operating result €111k, net result €84k, both a record.
31-12
Financial Equity above €500kEq €574k ▲17.1%
2 profitable years in a row build equity to €574k.
21-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 21 days late
2018
14-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 14 days late
2017
23-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Heusden-Zolder · 1 establishment unit since 2003
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Meylandtlaan 1593550 Heusden-Zolder
Ground area
1,074 m²
Building footprint
218 m²
Parcel 71065F0190/00M000, Flanders. Linked by address, not a title deed.
1 establishment unit
VALKENBORG
Meylandtlaan 159, 3550 Heusden-ZolderRetail sale of pharmaceutical products
since 20032.134.198.651
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71065F0190/00M000 Flanders 1,074 m² 1 · 218 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 7,321 companies in sector 68110 we hold annual accounts for 5,382. 3,391 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company (pre-2019)
Founded11-04-2003
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
68110Buying and selling of own real estate
70120
64200Holdings
64210Activities of holding companies
74151
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers

Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.